"Yale New Haven Hospital offers convenient access to skilled specialist and advanced healthcare treatments closer to home at Shoreline Medical Center. Shoreline Medical Center features outpatient healthcare services including blood draw, medical imaging, endoscopy, pain management, same-day outpatient surgery, heart and vascular services and a Smilow Cancer Hospital Care Center. There is also a full-service emergency department onsite staffed 24 hours a day, 7 days a week."

During the past decade, Yale-New Haven Shoreline Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale-New Haven Shoreline Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yale-New Haven Shoreline Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (3 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Stage IIIA Breast Cancer" (2 trials), "Stage IIIC Breast Cancer" (2 trials) and "ATM Gene Mutation" (1 trials). Many other conditions were trialed in "Yale-New Haven Shoreline Medical Center" in a lesser frequency.

Most popular intervention types in "Yale-New Haven Shoreline Medical Center" are "Drug" (8 trials), "Other" (8 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Ipilimumab" (2 trials), "Nivolumab" (2 trials), "Pharmacological Study" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yale-New Haven Shoreline Medical Center" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yale-New Haven Shoreline Medical Center". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Yale-New Haven Shoreline Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale-New Haven Shoreline Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".